Genkyotex
Manufacturing · France · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2 Forum 218, Archamps, Auvergne-Rhone-Al...Phone Number
+33 561287060Website
www.genkyotex.comRevenue
<$5 MillionIndustry
ZI Rank: 1
About Genkyotex
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Genkyotex your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Genkyotex has recently received funding, and reach out quickly before it becomes old news!
Genkyotex, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Genkyotex recently announced quarterly report
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Genkyotex has new funding data
Check out if Genkyotex is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Genkyotex
Product Launch: Get notified when Genkyotex launches new products
Click to see if Genkyotex had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at Genkyotex
Find more new buyers
Company Profile Activity
Activity Insights
Genkyotex is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Genkyotex is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Genkyotex.
Genkyotex Tech Stack
A closer look at the technologies used by Genkyotex
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Genkyotex
Calliditas Therapeutics AB specializes in the development of innovative therapies, particularly focusing on the NOX inhibitor platform. Their products include setanaxib, aimed at addressing unmet medical needs. The company targets healthcare providers and patients in need of advanced treatment options. As a wholly owned subsidiary, they continue to... Read More
